insights_auto
Outlook: 58.8% bullish·5.9% bearish
Go to analysischevron_right
INCY:NASDAQ
Incyte Corp
US$ १२३.४२
arrow_upward
+०.१८%(+०.२२) 1D
सेप्टेम्बर ३०, १४:११:५४ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
US$ १२३.००
High
US$ १२४.२३
Low
US$ १२२.०२
Mkt. cap
२५.०२ अरब
Avg. vol.
१४.०७ लाख
Volume
३.५९ लाख
P/E ratio
१५.७३
52-wk high
US$ १३२.५८
52-wk low
US$ ८२.८२
EPS
US$ ७.८५
Beta
०.७७
Shares outstanding
२०.२७ करोड
No. of employees
३ हजार
Open
US$ १२३.००
High
US$ १२४.२३
Low
US$ १२२.०२
Mkt. cap
२५.०२ अरब
Avg. vol.
१४.०७ लाख
Volume
३.५९ लाख
P/E ratio
१५.७३
52-wk high
US$ १३२.५८
52-wk low
US$ ८२.८२
EPS
US$ ७.८५
Beta
०.७७
Shares outstanding
२०.२७ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
Zacks
·
२ घण्टा पहिले
INCY or TECH: Which Is the Better Value Stock Right Now?
Yahoo Finance
·
३ घण्टा पहिले
INCY or TECH: Which Is the Better Value Stock Right Now?
The Global Legal Post
·
११ घण्टा पहिले
Diabetes tech company MiniMed hires ex-Incyte GC as next legal head
Simply Wall St
·
११ घण्टा पहिले
Learn Why The Bull Case For Incyte (INCY) Could Change Following Rare Disease Drug Approval
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees२.८४ हजार
Founded२००२
HeadquartersWilmington, डेलावेयर, संयुक्त राज्य अमेरिका
Sector-
Websiteincyte.com